| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 4 | |
| #2 | New Zealand | 4 | |
| #3 | Brazil | 3 | |
| #4 | China | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Electrotherapy | |
| #5 | Climate change adaptation technologies | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gelder Frank B | 17 |
| #2 | Webster Gillian Alison | 14 |
| #3 | Webster Gillian A | 2 |
| #4 | Alison Webster Gillian | 2 |
| #5 | Gelder B Frank | 1 |
| Publication | Filing date | Title |
|---|---|---|
| NZ577731A | Compositions and methods for treatment of multiple sclerosis | |
| EP2268289A1 | Anti-infective agents and uses thereof | |
| NZ567096A | Compositions and methods for treatment of neoplastic disease | |
| NZ567095A | Anti-infective agent and use thereof | |
| NZ571665A | Compositions and methods for treatment of radiation exposure utilising cross-linked muramyl dipeptide microparticles |